These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma. Arce J; Gaya JM; Huguet J; Rodriguez O; Palou J; Villavicencio H Can J Urol; 2011 Feb; 18(1):5529-36. PubMed ID: 21333045 [TBL] [Abstract][Full Text] [Related]
8. Carcinoma in situ developing in an ileal neobladder. Ide H; Kikuchi E; Shinoda K; Mukai M; Murai M Urology; 2007 Mar; 69(3):576.e9-11. PubMed ID: 17382181 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous prepubic urethrectomy with radical cystectomy for transitional cell carcinoma of the bladder. Zhang G Tech Urol; 1997; 3(2):72-5. PubMed ID: 9297765 [TBL] [Abstract][Full Text] [Related]
10. Radical cystectomy with or without urethrectomy? Van Poppel H; Sorgeloose T Crit Rev Oncol Hematol; 2003 Aug; 47(2):141-5. PubMed ID: 12900007 [TBL] [Abstract][Full Text] [Related]
11. [Urethral tumor recurrence following radical cystoprostatectomy--an indication for primary cystoprostato-urethrectomy?]. Gökcebay E; Riedmiller H; Stöckle M; Hohenfellner R Urologe A; 1989 Jul; 28(4):199-203. PubMed ID: 2763395 [TBL] [Abstract][Full Text] [Related]
13. Urothelial carcinoma in the prostatic urethra and prostate: current controversies. Liedberg F; Chebil G; Månsson W Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657 [TBL] [Abstract][Full Text] [Related]
14. [Urethral recurrence after cysto-prostatectomy for bladder tumor]. Robert M; Burgel JS; Serre I; Guiter J; Grasset D Prog Urol; 1996; 6(4):558-63. PubMed ID: 8924933 [TBL] [Abstract][Full Text] [Related]
15. [Indications for urethrectomy in male patients undergoing radical cystectomy in bladder carcinoma]. Hasuo K; Ariyoshi A; Kajiwara I Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2520-4. PubMed ID: 3209921 [No Abstract] [Full Text] [Related]
16. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. Lin DW; Herr HW; Dalbagni G J Urol; 2003 Mar; 169(3):961-3. PubMed ID: 12576822 [TBL] [Abstract][Full Text] [Related]
17. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy. Hassan JM; Cookson MS; Smith JA; Johnson DL; Chang SS J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989 [TBL] [Abstract][Full Text] [Related]
18. Expression of integrin proteins in non-muscle-invasive bladder cancer: significance of intravesical recurrence after transurethral resection. Behnsawy HM; Miyake H; Abdalla MA; Sayed MA; Ahmed Ael-F; Fujisawa M BJU Int; 2011 Jan; 107(2):240-6. PubMed ID: 20735384 [TBL] [Abstract][Full Text] [Related]
19. Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer. Hakozaki K; Kikuchi E; Ogihara K; Shigeta K; Abe T; Miyazaki Y; Kaneko G; Maeda T; Yoshimine S; Kanai K; Ide H; Shirotake S; Oyama M; Mizuno R; Oya M Jpn J Clin Oncol; 2021 Feb; 51(2):287-295. PubMed ID: 32893303 [TBL] [Abstract][Full Text] [Related]
20. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder. Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]